Showing results (31-40 of 112) with videos related to
Sort By:
Pageof 12
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 4, 2014
Binding of Clostridium botulinum C3 exoenzyme to intact cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.Toxins|February 5, 2015
Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.Journal of Molecular Signaling|September 14, 2018
Anti-proliferative Effect of C3 Exoenzyme in Fibroblasts is Mediated by c-Jun PhosphorylationLeonie von Elsner, Sandra Hagemann, Ingo Just, et al.The International Journal of Biochemistry & Cell Biology|February 22, 2008
Clostridium difficile toxins: more than mere inhibitors of Rho proteinsHarald Genth, Stefanie C Dreger, Johannes Huelsenbeck, et al.Nutrients|December 23, 2022
Physical Fitness, Nutrition and Quality of Life in German Medical StudentsLukas Walnik, Momme Kück, Uwe Tegtbur, et al.Infection and Immunity|September 22, 2006
Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effectsMatthias Teichert, Helma Tatge, Janett Schoentaube, et al.The FEBS Journal|May 25, 2012
Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174QAstrid Rohrbeck, Tanja Kolbe, Sandra Hagemann, et al.Biochemical and Biophysical Research Communications|February 21, 2003
Activation of phospholipase D1 by ADP-ribosylated RhoAHarald Genth, Martina Schmidt, Ralf Gerhard, et al.Biochemical and Biophysical Research Communications|January 1, 2003
The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosisCornelia Frisch, Ralf Gerhard, Klaus Aktories, et al.The Journal of Biological Chemistry|March 29, 2007
Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKCSabine Conrad, Harald Genth, Fred Hofmann, et al.Pageof 12